NDAINTRAVENOUSSOLUTION
Approved
Dec 2020
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GALLIUM GA 68 GOZETOTIDE (gallium ga-68 gozetotide) by Angeles Therapeutics is positron emitting activity [moa]. First approved in 2020.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium GA-68 Gozetotide is a radioactive diagnostic agent that emits positrons for positron emission tomography (PET) imaging. It is administered intravenously as a solution to enable visualization and detection of specific biological targets. The drug represents a specialized nuclear medicine product in the diagnostic imaging space.
Peak
Product is at peak lifecycle stage with moderate competitive pressure (30), indicating stable commercial positioning but potential resource constraints as market matures.
Mechanism of Action
Positron Emitting Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium GA-68 Gozetotide offers career opportunities in the specialized nuclear medicine and diagnostic imaging space, a niche sector with distinct technical and regulatory requirements. Professional growth depends on expertise in radiopharmaceutical marketing, regulatory compliance, and healthcare provider relationships in nuclear medicine centers.
Nuclear Medicine Specialist
Worked on GALLIUM GA 68 GOZETOTIDE at Angeles Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.